646 related articles for article (PubMed ID: 24125429)
1. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk factors in inflammatory arthritis.
Mirjafari H; Al-Husain A; Bruce IN
Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
[TBL] [Abstract][Full Text] [Related]
4. Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Shen J; Shang Q; Tam LS
Transl Res; 2016 Jan; 167(1):138-51. PubMed ID: 26051628
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk in rheumatoid arthritis.
Nurmohamed MT
Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
Giollo A; Bissell LA; Buch MH
Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
[TBL] [Abstract][Full Text] [Related]
7. Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.
Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S
J Rheumatol; 2012 Jul; 39(7):1341-7. PubMed ID: 22660798
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
Avouac J; Allanore Y
Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
[TBL] [Abstract][Full Text] [Related]
9. Triggers of Cardiovascular Diseases in Rheumatoid Arthritis.
Zhang M; Wang M; Tai Y; Tao J; Zhou W; Han Y; Wei Wei ; Wang Q
Curr Probl Cardiol; 2022 Jun; 47(6):100853. PubMed ID: 34016483
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?
Day AL; Singh JA
Drugs Aging; 2019 Jun; 36(6):493-510. PubMed ID: 30953327
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
Sanders S; Geraci SA
J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.
Barbhaiya M; Solomon DH
Curr Opin Rheumatol; 2013 May; 25(3):317-24. PubMed ID: 23466960
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease in rheumatoid arthritis.
Sen D; González-Mayda M; Brasington RD
Rheum Dis Clin North Am; 2014 Feb; 40(1):27-49. PubMed ID: 24268008
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease in rheumatoid arthritis.
Gonzalez-Gay MA; Gonzalez-Juanatey C; Miranda-Filloy JA; Garcia-Porrua C; Llorca J; Martin J
Biomed Pharmacother; 2006 Dec; 60(10):673-7. PubMed ID: 17049201
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis.
Bili A; Tang X; Pranesh S; Bozaite R; Morris SJ; Antohe JL; Kirchner HL; Wasko MC
Arthritis Care Res (Hoboken); 2014 Mar; 66(3):355-63. PubMed ID: 24023053
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
17. [Rheumatoid arthritis: a cardiovascular disease?].
Daïen CI; Fesler P
Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.
Pieringer H; Pichler M
QJM; 2011 Jan; 104(1):13-26. PubMed ID: 21068083
[TBL] [Abstract][Full Text] [Related]
19. Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.
Chighizola C; Schioppo T; Ingegnoli F; Meroni PL
Curr Vasc Pharmacol; 2012 Sep; 10(5):639-46. PubMed ID: 22272912
[TBL] [Abstract][Full Text] [Related]
20. Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.
Toussirot É
Expert Opin Drug Saf; 2015 Apr; 14(4):525-32. PubMed ID: 25599626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
